MedMira, Inc. (CVE:MIR) | Finanzwire

Basculer en Français

9473	Companies
185416	Keywords
117771	Articles
99291	Press releases

Home
Companies
MedMira, Inc.

PRESS RELEASE

published on 02/01/2024 at 14:10, 1 year 10 months ago

CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products
MedMira Inc. provides an update on its submission to Health Canada, extending its intended use to address the increasing need in maternity screening. The company's syphilis component demonstrates promising results, with plans to submit a comprehensive dataset for additional claims approval by February 2024

MedMira Inc. Maternity Screening Health Canada Syphilis Comprehensive Dataset
PRESS RELEASE

published on 02/01/2024 at 13:35, 1 year 10 months ago

Corporate Update on Clinical Evaluation of MedMira’s Products
MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening

MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance
PRESS RELEASE

published on 12/30/2023 at 05:00, 1 year 11 months ago

MedMira Reports First Quarter Results FY2024
MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States.
PRESS RELEASE

published on 12/14/2023 at 04:30, 1 year 11 months ago

U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
PRESS RELEASE

published on 11/29/2023 at 05:00, 2 years ago

MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
PRESS RELEASE

published on 09/28/2023 at 04:00, 2 years 2 months ago

Update on MedMira’s Regulatory Path in Canada and the USA
PRESS RELEASE

published on 08/31/2023 at 04:00, 2 years 3 months ago

Progress Update on Securities
PRESS RELEASE

published on 06/30/2023 at 04:00, 2 years 5 months ago

MedMira Reports Third Quarter Results FY2023
PRESS RELEASE

published on 04/04/2023 at 03:00, 2 years 8 months ago

MedMira Reports Second Quarter Results FY2023
PRESS RELEASE

published on 03/14/2023 at 21:31, 2 years 8 months ago

Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 10 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 15 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 45 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 40 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 45 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:30, 15 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 40 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 44 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 45 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 45 minutes ago

Official List Notice

Les Echos

Published on 12/05/2025 at 08:45, 1 hour ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 45 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 1 minute ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE